
    
      Serological surveys measuring anti-severe acute respiratory syndrome coronavirus 2
      (anti-SARS-CoV-2) antibodies in the population to assess the extent of the infection and the
      COVID-19 immunity of the population in French Guiana.

      This study is a interventional study that present minimal risks and constraints.

      The results of the study will allow estimation of COVID-19 virus infection, severity and
      attack rates, as well as inform public health responses and policy decisions in the French
      Guiana territory.
    
  